SIGLEC9 exhibited an increasing trend in the cancer and metastasis groups, although the statistical significance was not reached, possibly due to the small sample size of the normal and metastasis groups.
← all excerpts
The role of SIGLEC9 in immunosuppression and prognosis in cervical cancer.
1
—
—